Infinity Pharmaceuticals Inc (NASDAQ:INFI)
| 0.635 Delayed Data As of 3:14pm ET |  -0.001 / -0.16%Today’s Change | 0.44 Today|||52-Week Range 1.76 | +14.41% Year-to-Date |
Latest INFI News | Press Releases
No recent news for Infinity Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.64 |
| Today’s open | 0.65 |
| Day’s range | 0.64 - 0.66 |
| Volume | 8,300 |
| Average volume (3 months) | 553,582 |
| Market cap | $57.2M |
Data as of 3:14pm ET, 02/02/2023
Growth & Valuation
| Earnings growth (last year) | +21.83% |
| Earnings growth (this year) | +19.50% |
| Earnings growth (next 5 years) | +15.00% |
| Revenue growth (last year) | +8.09% |
| P/E ratio | NM |
| Price/Sales | 103.66 |
| Price/Book | 2.65 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SCYXSCYNEXIS Inc | +0.04 | +2.35% |
| HEPAHepion Pharmaceutica... | +0.03 | +4.00% |
| TCRRTCR2 Therapeutics In... | -0.07 | -4.93% |
| ---- |
Data as of 3:59pm ET, 02/02/2023
Financials
| Next reporting date | March 14, 2023 |
| EPS forecast (this quarter) | -$0.03 |
| Annual revenue (last year) | $1.9M |
| Annual profit (last year) | -$45.3M |
| Net profit margin | -2,436.06% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
